Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens. Lyles RDZ, Martinez MJ, Sherman B, Schurer S, et al. PLoS One 2023;18:e0287126.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lyles RDZ, Martinez MJ, Sherman B, Schurer S, et al. Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens. PLoS One 2023;18:e0287126.
PMID: 37815978